Quest PharmaTech Inc. QPTFF
OTC PK
| 07/31/2026 | 04/30/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -1.70% | -51.94% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -1.79% | -37.02% | |||
| Operating Income | 1.79% | 37.02% | |||
| Income Before Tax | -1.80% | -94.33% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -1.80% | -94.33% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -1.80% | -94.33% | |||
| EBIT | 1.79% | 37.02% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 0.00% | -94.48% | |||
| Normalized Basic EPS | 0.00% | -113.89% | |||
| EPS Diluted | 0.00% | -94.48% | |||
| Normalized Diluted EPS | 0.00% | -113.89% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||